AR006890A1 - Compuestos alquil-4-silil-fenoles y esteres de los mismos como agentes antiateroscleroticos - Google Patents
Compuestos alquil-4-silil-fenoles y esteres de los mismos como agentes antiateroscleroticosInfo
- Publication number
- AR006890A1 AR006890A1 ARP970101749A ARP970101749A AR006890A1 AR 006890 A1 AR006890 A1 AR 006890A1 AR P970101749 A ARP970101749 A AR P970101749A AR P970101749 A ARP970101749 A AR P970101749A AR 006890 A1 AR006890 A1 AR 006890A1
- Authority
- AR
- Argentina
- Prior art keywords
- alkyl
- silyl
- esters
- same
- hydrogen
- Prior art date
Links
- 230000000879 anti-atherosclerotic effect Effects 0.000 title abstract 2
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 5
- 229910052739 hydrogen Inorganic materials 0.000 abstract 4
- 239000001257 hydrogen Substances 0.000 abstract 4
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 4
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 abstract 4
- 125000002947 alkylene group Chemical group 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical group 0.000 abstract 1
- -1 hydroxy, methoxy, ethoxy Chemical group 0.000 abstract 1
- 125000001624 naphthyl group Chemical group 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
- 125000000446 sulfanediyl group Chemical group *S* 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/0803—Compounds with Si-C or Si-Si linkages
- C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Los alquil-4-silil-fenoles y ésteres de los mismos como agentes antiateroscleróticos tienen la fórmula (I), donde R1 y R6 son cada unoindependientemente alquilo C1-C6; R2, R3 y R4 son cada uno independientemente hidrógeno o alquilo C1-C6; R es hidrógeno o -C(O)-(CH2)m-Q, donde Q eshidrógeno o -COOH y m es un entero 1, 2, 3 o 4; Z es tio, oxi o un grupo metileno; A es un grupo alquileno C1-C4; R5 y R7 son cada unoindependientemente un alquilo C1-C6 o -(CH2)n-(Ar) donde n es un entero 0, 1, 2 o 3; y Ar es fenilo o naftilo sin sustituir o sustituido con uno a tressustituyentes seleccionados del grupo formado por hidroxi, metoxi, etoxi, halógeno, trifluormetilo, alquilo C1-C6, o -NR8R9, donde R8 y R9 son cada unoindependientemente hidrógeno o alquilo C1-C6; con la condición de que cuando R2 y al menos uno de R5 o R7 es alquilo C1-C6, y Ar no está sustituido contrifluormetilo o -NR8R9, entonces R sea -C(O)-(CH2)m-Q; y pueden ser una sal farmacéuticamente aceptable de los mismos.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/637,968 US5608095A (en) | 1996-04-30 | 1996-04-30 | Alkyl-4-silyl-phenols and esters thereof as antiatherosclerotic agents |
Publications (1)
Publication Number | Publication Date |
---|---|
AR006890A1 true AR006890A1 (es) | 1999-09-29 |
Family
ID=24558107
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP970101749A AR006890A1 (es) | 1996-04-30 | 1997-04-29 | Compuestos alquil-4-silil-fenoles y esteres de los mismos como agentes antiateroscleroticos |
Country Status (19)
Country | Link |
---|---|
US (1) | US5608095A (es) |
EP (1) | EP0900225B1 (es) |
JP (1) | JP4309473B2 (es) |
KR (1) | KR100503181B1 (es) |
CN (1) | CN1216993A (es) |
AR (1) | AR006890A1 (es) |
AT (1) | ATE212639T1 (es) |
AU (1) | AU711322B2 (es) |
BR (1) | BR9709190A (es) |
CA (1) | CA2251991C (es) |
DE (1) | DE69710191T2 (es) |
DK (1) | DK0900225T3 (es) |
ES (1) | ES2167716T3 (es) |
IL (1) | IL126758A0 (es) |
NO (1) | NO985039L (es) |
PT (1) | PT900225E (es) |
TW (1) | TW474940B (es) |
WO (1) | WO1997041129A1 (es) |
ZA (1) | ZA973503B (es) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5795876A (en) * | 1996-04-30 | 1998-08-18 | Hoechst Marion Rousssel, Inc. | Method of inhibiting vascular cell adhesion molecule-1 and treating chronic inflammatory diseases with 2, 6-di-alkyl-4-silyl-phenols |
IL126744A0 (en) * | 1996-04-30 | 1999-08-17 | Hoechst Marion Roussel Inc | Method of inhibiting vascular cell adhesion molecule-1 and treating chronic inflammatory diseases with 2,6-Di-alkyl-4-silyl-phenols |
US6670398B2 (en) | 1997-05-14 | 2003-12-30 | Atherogenics, Inc. | Compounds and methods for treating transplant rejection |
EA200800375A1 (ru) | 1997-05-14 | 2008-06-30 | Атеродженикс, Инк. | Соединения и способы ингибирования экспрессии vcam-1 |
US6121463A (en) * | 1997-06-24 | 2000-09-19 | Hoechst Marion Roussel, Inc. | Alkyl-4-silylheterocyclic phenols and thiophenols useful as antioxidant agents |
EP0996623A1 (en) * | 1997-06-25 | 2000-05-03 | Hoechst Marion Roussel, Inc. | 2,6-DI-t-BUTYL-4- (DIMETHYL-4-METHOXYPHENYLSILYL) -METHYLOXY]PHENOL AND 2,6-DI-t-BUTYL-4- (DIMETHYL-2-METHOXY-PHENYLSILYL) -METHYLOXY]PHENOL |
US6133467A (en) * | 1997-06-25 | 2000-10-17 | Hoechst Marion Roussel, Inc. | 2,6-di-t-butyl-4-[(dimethyl-4-methoxyphenylsilyl)-methyl-oxy]phenol and 2,6-di-t-butyl-4-[(dimethyl-2-methoxy-phenylsilyl)methyloxy]phenol |
AU8282798A (en) * | 1997-07-01 | 1999-01-25 | Atherogenics, Inc. | Antioxidant enhancement of therapy for hyperproliferative conditions |
US6887712B1 (en) | 1998-11-09 | 2005-05-03 | Atherogenics, Inc. | Methods and compositions to lower plasma cholesterol levels |
WO2000028332A1 (en) * | 1998-11-09 | 2000-05-18 | Atherogenics, Inc. | Methods and compositions to lower plasma cholesterol levels |
US6020383A (en) * | 1999-01-11 | 2000-02-01 | Eastman Chemicals Company | Method for reducing blood cholesterol and/or blood triglycerides |
CA2428753C (en) | 2000-11-17 | 2013-05-21 | Idenix (Cayman) Limited | Methods for inhibiting the transmission of hiv using topically applied substituted 6-benzyl-4-oxopyrimidines |
JP4334233B2 (ja) * | 2001-04-11 | 2009-09-30 | アセロジエニクス・インコーポレイテツド | プロブコールモノエステルによって血漿hdlコレステロールレベルを上昇させ、hdlの機能性を改善するための方法 |
CN100512809C (zh) * | 2001-10-25 | 2009-07-15 | 阿特罗吉尼克斯公司 | 化合物在制备用于慢性移植排斥的药物中的用途 |
KR20050044352A (ko) * | 2001-11-09 | 2005-05-12 | 아테로제닉스, 인코포레이티드 | 심혈관 병리의 역전 및 예방 방법 |
RU2004121898A (ru) * | 2001-12-19 | 2006-01-20 | Атеродженикс, Инк. (Us) | Производные халкона и их применение для лечения заболеваний |
CA2492433A1 (en) * | 2002-07-12 | 2004-01-22 | Artherogenics, Inc. | Organic amine salts of poorly soluble probucol esters and ethers |
US20040110803A1 (en) * | 2002-09-13 | 2004-06-10 | Hossein Dovlatabadi | Methods and compositions for the use of D-malic acid to decrease serum triglyceride, cholesterol and lipoprotein levels |
AU2003303239A1 (en) * | 2002-12-19 | 2004-07-14 | Atherogenics, Inc. | Process of making chalcone derivatives |
MXPA05007548A (es) * | 2003-01-13 | 2005-10-20 | Atherogenics Inc | Procedimiento para preparar esteres y eteres de probucol y derivados del mismo. |
US7173129B2 (en) * | 2003-06-06 | 2007-02-06 | Athero Genics, Inc. | Sulfonamide-substituted chalcone derivatives and their use to treat diseases |
WO2005039596A1 (en) * | 2003-10-17 | 2005-05-06 | Amylin Pharmaceuticals, Inc. | Silyl phenols for promoting vascular health |
WO2005102323A2 (en) | 2004-04-20 | 2005-11-03 | Atherogenics, Inc. | Process of preparing esters and ethers of probucol and derivatives thereof |
WO2005112914A2 (en) | 2004-04-20 | 2005-12-01 | Atherogenics, Inc. | Phenolic antioxidants for the treatment of disorders including arthritis, asthma and coronary artery disease |
WO2006004903A2 (en) * | 2004-06-28 | 2006-01-12 | Atherogenics, Inc. | 1,2-bis-(substituted-phenyl)-2-propen-1-ones and pharmaceutical compositions thereof |
CA2571589A1 (en) * | 2004-07-01 | 2006-01-19 | Atherogenics, Inc. | Compounds and methods for treating diabetic vascular diseases |
AU2008230861A1 (en) * | 2007-03-26 | 2008-10-02 | Salutria Pharmaceuticals, Llc | Methods and compositions of derivatives of probucol for the treatment of diabetes |
US20080280985A1 (en) * | 2007-03-27 | 2008-11-13 | Scott Robert A D | Methods and Compositions Using Certain Phenolic Derivatives for the Treatment of Diabetes |
JP5778755B2 (ja) * | 2010-04-15 | 2015-09-16 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングMerck Patent Gesellschaft mit beschraenkter Haftung | ヒドロキノンの製造方法 |
CN109641004A (zh) | 2016-07-08 | 2019-04-16 | 燕财成有限公司 | 实体癌治疗剂 |
Family Cites Families (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3129262A (en) * | 1962-10-08 | 1964-04-14 | Consolidation Coal Co | Reduction of organic thiocyanates |
US3862332A (en) * | 1967-05-11 | 1975-01-21 | Dow Chemical Co | Method of lowering serum cholesterol |
US3576883A (en) * | 1969-06-30 | 1971-04-27 | Consolidation Coal Co | Alkylidenedithiobisphenols |
US3897500A (en) * | 1971-12-10 | 1975-07-29 | Continental Oil Co | Alkylidenedithiobisphenols |
US3786100A (en) * | 1971-12-10 | 1974-01-15 | Continental Oil Co | Keto substituted alkylidenedithiobisphenols |
JPS61263988A (ja) * | 1985-05-16 | 1986-11-21 | Shionogi & Co Ltd | シリル置換エ−テル類および殺虫・殺ダニ剤 |
US5356917A (en) * | 1985-08-09 | 1994-10-18 | Eli Lilly And Company | Aryl-substituted rhodanine derivatives |
US4719237A (en) * | 1986-01-28 | 1988-01-12 | Merrell Dow Pharmaceuticals Inc. | Cardiac antiarrythmic method employing probucol |
US4734527A (en) * | 1986-10-17 | 1988-03-29 | Merrell Dow Pharmaceuticals Inc. | Process for preparing 2,6-di-tertiarybutyl-4-mercaptophenol |
US4772363A (en) * | 1987-01-14 | 1988-09-20 | Merrell Dow Pharmaceuticals Inc. | Process for preparing 2,6-di-tertiarybutyl-4-mercaptophenol by electrocatalysis |
US4861443A (en) * | 1987-01-14 | 1989-08-29 | Merrell Dow Pharmaceuticals Inc. | Process for preparing 4,4'-isopropylidenedithio-bis-(2,6-di-tertiarybutylphenol) by electrocatalysis |
US5401883A (en) * | 1987-01-20 | 1995-03-28 | Merrell Dow Pharmaceuticals Inc. | Process for preparing 2,6-di-tertiarybutyl-4-mercaptophenol and 4,4'-isopropylidenedithio-bis-(2,6-di-tertiarybutylphenol) |
US4975467A (en) * | 1987-03-17 | 1990-12-04 | Merrell Dow Pharmaceuticals Inc. | Method of inhibiting interleukin-1 release and alleviating interleukin-1 mediated conditions |
JPH0813824B2 (ja) * | 1988-10-27 | 1996-02-14 | 北興化学工業株式会社 | 有機ケイ素化合物 |
US4900757A (en) * | 1988-12-08 | 1990-02-13 | Merrell Dow Pharmaceuticals Inc. | Hypocholesterolemic and antiatherosclerotic uses of bix(3,5-di-tertiary-butyl-4-hydroxyphenylthio)methane |
US5047555A (en) * | 1988-12-13 | 1991-09-10 | Tanabe Seiyaku Co., Ltd. | 4-aminophenol derivatives and processes for preparing the same |
US5272263A (en) * | 1989-04-28 | 1993-12-21 | Biogen, Inc. | DNA sequences encoding vascular cell adhesion molecules (VCAMS) |
US5217870A (en) * | 1989-04-28 | 1993-06-08 | Biogen, Inc. | Monoclonal antibodies against CDX |
US5008421A (en) * | 1989-07-05 | 1991-04-16 | Aristech Chemical Corporation | Silyl derivatives of 2,6-dimethyl-4-allyl phenol |
DE3935638A1 (de) * | 1989-10-26 | 1991-05-02 | Consortium Elektrochem Ind | Organosilylalkylaromaten |
US5061734A (en) * | 1990-05-09 | 1991-10-29 | Merrell Dow Pharmaceuticals Inc. | Bis(alkyl-substituted-4-hydroxyphenylthio)alkane analogs as inhibitors of cataractogenesis |
US5112870A (en) * | 1990-05-09 | 1992-05-12 | Merrell Dow Pharmaceuticals Inc. | Bis(alkyl-substituted-4-hydroxyphenylthio)alkane analogs as inhibitors of cataractogenesis |
JP2899064B2 (ja) * | 1990-05-23 | 1999-06-02 | キヤノン株式会社 | 液晶性化合物、これを含む液晶組成物およびこれを使用した液晶素子 |
US5304668A (en) * | 1990-07-05 | 1994-04-19 | Merrell Dow Pharmaceuticals | Bis-[4-(2,6-di-alkyl)phenolisilane derivatives as antiatherosclerotic agents |
NZ238807A (en) * | 1990-07-05 | 1994-03-25 | Merrell Dow Pharma | Bis[4-(2,6-dialkyl)phenol]silane derivatives and antiatherosclerotic compositions |
US5155250A (en) * | 1990-07-05 | 1992-10-13 | Merrell Dow Pharmaceuticals Inc. | 2,6-di-alkyl-4-silyl-phenols as antiatheroscerotic agents |
US5254549A (en) * | 1991-12-19 | 1993-10-19 | Merz & Co. Gmbh & Co. | New BHT ether compounds and their use as hypolipidemic and antiatherosclerotic drugs |
US5262439A (en) * | 1992-04-30 | 1993-11-16 | The Regents Of The University Of California | Soluble analogs of probucol |
NZ299210A (en) * | 1992-09-02 | 2000-08-25 | Isis Pharmaceuticals Inc | Treating diseases characterised by changes in intercellular adhesion molecules using coding sequences hybridizable with those encoding proteins involved in synthesis of such molecules |
US5380747A (en) * | 1992-10-30 | 1995-01-10 | Emory University | Treatment for atherosclerosis and other cardiovascular and inflammatory diseases |
WO1994011027A1 (en) * | 1992-11-13 | 1994-05-26 | Board Of Regents Of University Of Washington | Peripheralization of hematopoietic stem cells |
AU5833494A (en) * | 1992-12-22 | 1994-07-19 | Smithkline Beecham Plc | Piperidine derivatives as calcium channel antagonists |
DE69419721T2 (de) * | 1993-01-12 | 2000-04-27 | Biogen, Inc. | Rekombinante anti-vla4 antikörpermoleküle |
NZ262615A (en) * | 1993-02-09 | 1996-02-27 | Biogen Inc | Treating insulin dependent diabetes (type i) with anti vla4 (very late antigen) antibodies |
AU7559894A (en) * | 1993-08-05 | 1995-02-28 | Isis Pharmaceuticals, Inc. | Oligomers for modulating metabolic function |
JP3650144B2 (ja) * | 1994-06-08 | 2005-05-18 | 花王株式会社 | 細胞接着抑制剤 |
-
1996
- 1996-04-30 US US08/637,968 patent/US5608095A/en not_active Expired - Fee Related
-
1997
- 1997-03-03 DK DK97907998T patent/DK0900225T3/da active
- 1997-03-03 JP JP53886297A patent/JP4309473B2/ja not_active Expired - Fee Related
- 1997-03-03 KR KR1019980708692A patent/KR100503181B1/ko not_active IP Right Cessation
- 1997-03-03 AT AT97907998T patent/ATE212639T1/de not_active IP Right Cessation
- 1997-03-03 ES ES97907998T patent/ES2167716T3/es not_active Expired - Lifetime
- 1997-03-03 PT PT97907998T patent/PT900225E/pt unknown
- 1997-03-03 WO PCT/US1997/003335 patent/WO1997041129A1/en active IP Right Grant
- 1997-03-03 DE DE69710191T patent/DE69710191T2/de not_active Expired - Fee Related
- 1997-03-03 EP EP97907998A patent/EP0900225B1/en not_active Expired - Lifetime
- 1997-03-03 IL IL12675897A patent/IL126758A0/xx unknown
- 1997-03-03 CA CA002251991A patent/CA2251991C/en not_active Expired - Fee Related
- 1997-03-03 BR BR9709190A patent/BR9709190A/pt active Search and Examination
- 1997-03-03 CN CN97194267A patent/CN1216993A/zh active Pending
- 1997-03-03 AU AU19854/97A patent/AU711322B2/en not_active Ceased
- 1997-04-23 TW TW086105269A patent/TW474940B/zh active
- 1997-04-23 ZA ZA9703503A patent/ZA973503B/xx unknown
- 1997-04-29 AR ARP970101749A patent/AR006890A1/es unknown
-
1998
- 1998-10-29 NO NO985039A patent/NO985039L/no unknown
Also Published As
Publication number | Publication date |
---|---|
BR9709190A (pt) | 1999-08-10 |
AU1985497A (en) | 1997-11-19 |
JP2001509782A (ja) | 2001-07-24 |
ES2167716T3 (es) | 2002-05-16 |
EP0900225A1 (en) | 1999-03-10 |
ZA973503B (en) | 1997-10-30 |
CA2251991C (en) | 2002-05-14 |
IL126758A0 (en) | 1999-08-17 |
AU711322B2 (en) | 1999-10-14 |
CN1216993A (zh) | 1999-05-19 |
DE69710191D1 (de) | 2002-03-14 |
NO985039L (no) | 1998-12-21 |
EP0900225B1 (en) | 2002-01-30 |
NO985039D0 (no) | 1998-10-29 |
DK0900225T3 (da) | 2002-05-13 |
ATE212639T1 (de) | 2002-02-15 |
PT900225E (pt) | 2002-06-28 |
TW474940B (en) | 2002-02-01 |
KR100503181B1 (ko) | 2006-03-03 |
CA2251991A1 (en) | 1997-11-06 |
JP4309473B2 (ja) | 2009-08-05 |
DE69710191T2 (de) | 2002-07-25 |
WO1997041129A1 (en) | 1997-11-06 |
US5608095A (en) | 1997-03-04 |
KR20000065101A (ko) | 2000-11-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR006890A1 (es) | Compuestos alquil-4-silil-fenoles y esteres de los mismos como agentes antiateroscleroticos | |
ES2194986T3 (es) | Compuestos de carbonil-piperazinilo y piperidinilo que inhiben la farnesil-protein-transferasa. | |
CO4810230A1 (es) | Nuevos derivados del 19-nor-pregneno | |
AR012032A1 (es) | Compuestos derivados 3'-n-oxido, 3'-n-dimetilamina, 9-oxima eritromicina a y un proceso para su preparacion | |
ID29452A (id) | 4-okso-1,4-dihidro-3-quinolinkarboksamida sebagai agen-agen antivirus | |
MX9304587A (es) | Derivados de 4-aza-5alfa-androstan-3-ona sustituidos en la posicion 17-beta, procedimiento para su preparacion y composiciones farmaceuticas que los contienen. | |
SE8004254L (sv) | Nya enkafalinderivat | |
EA200100983A1 (ru) | Производные 13-метилэритромицина | |
MY107001A (en) | Pharmaceutical compounds. | |
DK0984942T3 (da) | Flydende benz-iso-quinolinderivater | |
DE69206274D1 (de) | 3-ureido-benzodiazepinone verwendbar als cck- oder gastrin-antagonisten. | |
CO4700452A1 (es) | Derivados de indol | |
AU5551594A (en) | Substituted amino alkyl compounds | |
ES520860A0 (es) | Procedimiento de preparar teofilinas 7-substituidas. | |
CO5070654A1 (es) | Derivados de acidos fenilaminoalquilcarboxilicos y composiciones farmaceuticas que los comprenden | |
AR006891A1 (es) | Metodo de inhibicion de la molecula-1de adhesion celular vascular y tratamiento de enfermedades cronicas con 2,6-dialquil-4-sililfenoles | |
TW334425B (en) | Annelated dihydropyridines for preparing pharmaceutical preparations | |
TR199802163T2 (xx) | 4'-Triflorometilbifenil-2-karboksilik asit | |
CO5160255A1 (es) | DERIVADOS DE 4-OXO-3,5-DIHIDRO-4H-PIRIDAZINO[4,5-b]INDOL-1- CARBOXAMIDA Y COMPOSICIONES QUE LOS COMPRENDEN | |
SE8403268L (sv) | 1,4-dihydropyridinderivat, deras framstellning och farmaceutiska beredningar innehallande dessa | |
CO5180536A1 (es) | Inhibidores de proteasas catepsina | |
FI891087A (fi) | Nya kefemfoereningar och foerfarande foer deras framstaellning. | |
ES2117003T3 (es) | Derivados oligopeptidicos de hipoxantina dotados de actividad inmunomoduladora, y composiciones farmaceuticas que los contienen. | |
AR247737A1 (es) | Un procedimiento para la fabricacion de compuestos. | |
FI971177A0 (fi) | Bisyklisiä karboksiamideja 5-HT1A-antagonisteina |